Federal contractor · public award history
BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL
DBA BASILEA PHARMACEUTICA INTERNATIONAL SA, ALLSCHWIL
Parent: BASILEA PHARMACEUTICA AG Z9A6DMV55YP3
- Awards we know about
- 4
- Typical size
- $59.48M
- Middle of their public awards
- Dollars on those awards
- $242.68M
Most of their awards we can see fall roughly between $23.11M and $97.03M.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Public award activity by year
Sum of award values in our USAspending index (not a full financial history).
- 2024$13.10M
- 2025$229.58M
Awarding agencies
- Department of Health and Human Services (4)
Industries & product codes
Award history
- Department of Health and Human Services$26.45M
VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS.
- Department of Health and Human Services$110.63M
IGF::OT::IGF ADVANCED DEVELOPMENT OF CEFTOBIPROLE
- Department of Health and Human Services$92.50M
THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA
- Department of Health and Human Services$13.10M
IGF::OT::IGF FOR OTHER FUNCTIONS THIS CONTRACT IS FOR THE CLINICAL DEVELOPMENT OF BAL30072, A NOVEL MONOSULFACTAM FOR THE TREATMENT OF INFECTIONS CAUSED BY MULTI-DRUG RESISTANT GRAM-NEGATIVE BACTERIAL PATHOGENS.
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.